Sonnet BioTherapeutics Holdings, Inc. (SONN) has a market capitalization of $8.43M and trades at $1.26. The 52-week range is 1.08-19.3.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-3.95, annual revenue of $1M.
The stock has a beta of 1.47, operates in the Healthcare sector.
